Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

mMitra, a Free Voice Messaging Health Advisory Service Launched for Pregnant Women & Mothers at Sion Hospital, Mumbai


News provided by

Glenmark Pharmaceuticals Ltd

Dec 23, 2013, 08:03 ET

Share this article

Share toX

Share this article

Share toX

MUMBAI, December 23, 2013 /PRNewswire/ --

First of its kind public-private partnership between an NGO, Corporate and Government Institution, coming together for a social cause

Continue Reading
L to R – Dr. Ashwini Gandhi (Vice President, FOGSI), Dr. Aparna Hegde (Founder, Chairperson and Managing Trustee, ARMMAN), Mr. Jayant Banthia (Ex-Chief Secretary of Government of Maharashtra), Ms. Cheryl Pinto (Director, Corporate Affairs Glenmark), Dr. Mamta Manglani (HOD, Dept. of Paediatrics, LTMGH) (PRNewsFoto/Glenmark Pharmaceuticals Ltd)
L to R – Dr. Ashwini Gandhi (Vice President, FOGSI), Dr. Aparna Hegde (Founder, Chairperson and Managing Trustee, ARMMAN), Mr. Jayant Banthia (Ex-Chief Secretary of Government of Maharashtra), Ms. Cheryl Pinto (Director, Corporate Affairs Glenmark), Dr. Mamta Manglani (HOD, Dept. of Paediatrics, LTMGH) (PRNewsFoto/Glenmark Pharmaceuticals Ltd)

mMitra, a free mobile based Health Advisory Voice Messaging Service for pregnant women and mothers was launched at Lokmanya Tilak Municipal General Hospital (Sion Hospital) recently. Present on the occasion were Mr. Jayant Banthia (Ex-Chief Secretary of Government of Maharashtra), Dr. Ashwini Gandhi (Vice President, FOGSI), Dr. Aparna Hegde (Founder, Chairperson and Managing Trustee, ARMMAN), Ms. Cheryl Pinto (Director, Corporate Affairs Glenmark), Dr. Mamta Manglani (HOD, Dept. of Paediatrics, LTMGH) and other dignitaries.

     (Logo: http://photos.prnewswire.com/prnh/20130626/625083 )

     (Photo: http://photos.prnewswire.com/prnh/20131223/659802 )

Targeted at the less privileged pregnant women and mothers, the mMitra service will provide comprehensive information on preventive care with an objective of reducing maternal and infant mortality and morbidity. These medically verified voice messages will be sent in relevant regional languages and have been researched and developed to create the desired impact on even uneducated women.

The implementation of this innovative project has been made possible due to public-private partnership between Glenmark - a leading pharmaceutical company, NGO - ARMMAN and Lokmanya Tilak Municipal General Hospital, a leading medical institution.

Dr. Aparna Hegde, MD and Founder, Chairperson & Managing Trustee, ARMMAN, said, "mMitra was born  from my experience of being a Doctor  & Lecturer at Sion Hospital during which I saw several women developing complications during pregnancy and child birth which could have been avoided had they received preventive healthcare  information during this critical period. Also, as Public Hospitals are usually overcrowded, offering appropriate counseling to pregnant women is a quite a challenge for the Doctors.  mMitra is developed to envoy like a loyal friend and companion that will gently guide the woman through pregnancy and infancy."

Ms. Cheryl Pinto, Director, Corporate Affairs, Glenmark, said, "When Armman approached us with this concept of delivering informative and medically relevant voice messages for pregnant women and mothers, we realized the enormous potential of this idea - how through smart use of available technology we can play a huge role in impacting lives. It's also a model that's scalable and can be replicated by any institution desiring to improve public health in our country." She further added, "Public Private Partnership between Glenmark NGO ARMMAN and Lokmanya Tilak Municipal General Hospital has resulted in this transformational solution created with the ultimate objective of reducing maternal and child mortality and infant morbidity among the less privileged pregnant women and new mothers."

To start off around 5000 women attending the antenatal clinic of Sion hospital will now receive mMitra Voice Messages as a part of their antenatal and infancy care over two years. Medically verified, individualized voice messages of 60 - 90 seconds (145 messages in all) in Hindi or Marathi will be sent directly to the mobile phones of each enrolled woman with the following frequency:

  • Pregnancy: Two messages per week
  • First week after birth: Once a day
  • Infancy until month 3: Two messages per week
  • Infancy month 3 - month 12: One message per week

A timed and targeted behaviour change communication (BCC) is necessary to motivate people to adopt better antenatal, perinatal and infancy care practices. Counselling can lead to behaviour change only when the information is culturally specific, in the local language or dialect and reinforced by repetition over a period of time. A voice messaging service that disseminates information directly to the mother can improve and ensure that messages reach underprivileged, illiterate women and the most vulnerable group in urban India. Also, alternatives like text messages cannot be used in case of illiterate women and they also lack the emotional connect of voice messages.

About ARMMAN

ARMMAN primarily support poverty affected women and children, especially those women who are fighting with their fate to survive being single mothers, and work with the following vulnerable populations.  ARMAAN Welfare Foundation serves in the following areas like promoting health awareness, providing educational opportunities for children and supporting economic empowerment through small loans (microcredit) & training for women that facilitates entrepreneurship & fosters small business development.

About Glenmark Foundation

Glenmark Foundation (the CSR arm of Glenmark Group) has been actively engaged in strategising, implementing and creating social impact through community based programmes on issues related to Child Health and creating a Sustainable livelihood for the marginalized and vulnerable sections of our society. Glenmark Foundation is committed towards improving Child Health, which is its flagship CSR programme. Within the cause of Child Health it aims at addressing United Nation's Millennium Development Goal (MDG)-4 which is reducing child mortality.

The foundation has taken up projects in regions where both infant and child mortality is very high. It is working at the grassroots with its NGO partners in Khandwa, Madhya Pradesh (Central) India, Sangner, Rajasthan ( North-West India) and in slums of Andheri in Mumbai, Maharashtra (West India), Solan District, Himachal Pradesh & in slums of Kibera, Nairobi, Kenya.

http://www.glenmarkpharma.com

SOURCE Glenmark Pharmaceuticals Ltd

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)

Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)

Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC);...

Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg, 20 mg and 30 mg

Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg, 20 mg and 30 mg

Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the upcoming launch[1] of Dextroamphetamine Saccharate, Amphetamine Aspartate,...

More Releases From This Source

Explore

Banking & Financial Services

Banking & Financial Services

Computer & Electronics

Computer & Electronics

Networks

Networks

Networks

Networks

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.